The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHipgnosis Song. Regulatory News (SONG)

Share Price Information for Hipgnosis Song. (SONG)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 104.60
Bid: 104.60
Ask: 104.80
Change: -0.20 (-0.19%)
Spread: 0.20 (0.191%)
Open: 104.60
High: 105.20
Low: 104.40
Prev. Close: 104.80
SONG Live PriceLast checked at -
Hipgnosis Songs is an Investment Trust

To provide shareholders with an attractive and growing level of income, together with the potential for capital growth, from investment in songs and associated musical intellectual property rights.

Find out More

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Update on dividend intentions

6 Nov 2023 07:00

RNS Number : 4168S
Hipgnosis Songs Fund Limited
06 November 2023
 

This announcement contains inside information for the purposes of the UK Market Abuse Regulation.

 

LEI: 213800XJIPNDVKXMOC11

 

 

Hipgnosis Songs Fund Limited ("Hipgnosis" or the "Company")

 

Update on Dividend Intentions

6 November 2023 

 

The Board of Hipgnosis Songs Fund Limited together with its Investment Adviser, Hipgnosis Song Management Limited, have been undertaking a review of the Company's financial position as a result of which the Board has determined that it will not declare dividends before the new financial year.

As a result of this review:

· It has been determined that the Catalogue bonus provision is expected to increase by approximately $23 million to $68 million at 30 September 2023 as there are now ten (31 March 2023: six) out of the Company's 146 Catalogues likely to meet performance hurdles as defined in their acquisition agreements. The $68 million would be payable over a period of three years from 30 September 2023, with $40 million due within 12 months, $24 million due within 1-2 years and $4 million due within 2-3 years. In addition, there are a further nineteen Catalogues with active bonus provisions totalling $75 million, that are unlikely to meet performance hurdles; these are not recognised as provisions but are contingent liabilities and will be disclosed in the forthcoming interim results with associated sensitivity analysis.

 

· The Board, advised by the Investment Adviser, is exploring refinements to the methodology adopted in the Company's revenue accrual estimation process for the year end results which, based on early assessments, may result in an accrual adjustment reducing revenue accruals by up to 10%. Any changes would aim to bring consistency to the description of IFRS revenue and the Pro Forma Annual Revenue measure through the use of granular data in the underlying calculations, to support an improved estimation process and enhanced disclosures.

 

 

In light of this information, the Board has determined that it will not declare dividends before the new financial year. The operating cash flow of the Company during this time will therefore be used to ensure that the Company has sufficient cash resources to fund the payment of the Catalogue bonuses as required. Additionally, the suspension of dividend payments will provide the Company with the headroom required to maintain compliance with its revolving credit facility's Fixed Charge Cover Ratio covenant if the accrual adjustment is realised in full.

The Board will update the Company's dividend policy as part of proposals which are due to be made to shareholders by 26 April 2024 following completion of the Strategic Review.

The person responsible for making this notification is Sylvia Coleman, Senior Independent Director of Hipgnosis Songs Fund Limited.

 

 

For further information please contact:

 

Hipgnosis Songs Fund Limited

Sylvia Coleman

via Singer Capital Markets

+44 (0) 20 7496 3000

Hipgnosis Song Management

Merck Mercuriadis

Ben Katovsky

Giles Croot (Media)

+44 (0) 20 4542 1530

+44 (0) 20 4542 1511

Headland Consultancy - Financial PR

Susanna Voyle / Charlie Twigg

 

+44 (0) 20 3805 4822

J.P. Morgan Cazenove - Sponsor, Financial Adviser and Corporate Broker

William Simmonds / Jérémie Birnbaum (Corporate Finance)

+44 (0) 20 3493 8000

Singer Capital Markets - Corporate Broker

James Moat / Angus Campbell (Corporate Finance)

Alan Geeves / James Waterlow / Sam Greatrex (Sales) 

+44 (0) 20 7496 3000

RBC Capital Markets - Corporate Broker

Elliot Thomas / Max Avison (Corporate Finance)

 

+44 (0) 20 7635 4000

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DIVEAAFSEDADFAA
Date   Source Headline
3rd May 20237:00 amRNSDirectorate Change
16th Mar 20237:00 amRNSDividend Declaration
10th Mar 20235:00 pmRNSDirector/PDMR Shareholding
10th Mar 20234:50 pmRNSDirector/PDMR Shareholding
14th Feb 20237:00 amRNSDirector/PDMR Shareholding
3rd Jan 20237:00 amRNSTotal Voting Rights
23rd Dec 202211:53 amRNSPublication of Factsheet
13th Dec 20224:03 pmRNSHoldings in Company-Notification of Major Holdings
8th Dec 20227:01 amRNSDividend Declaration
8th Dec 20227:00 amRNSHalf-year Report
5th Dec 20227:00 amRNSTransaction in Own Shares
1st Dec 202210:05 amRNSTotal Voting Rights
30th Nov 20227:00 amRNSNotice: Half Year Results and Capital Markets Day
24th Nov 20226:06 pmRNSHolding(s) in Company
18th Nov 20227:00 amRNSTransaction in Own Shares
14th Nov 20223:29 pmRNSDirector/PDMR Shareholding
3rd Nov 20227:00 amRNSTransaction in Own Shares
2nd Nov 20227:00 amRNSKepler Trust Intelligence: New Research
2nd Nov 20227:00 amRNSTransaction in Own Shares
1st Nov 20227:01 amRNSTransaction in Own Shares
1st Nov 20227:00 amRNSTotal Voting Rights
31st Oct 20227:00 amRNSTransaction in Own Shares
26th Oct 20223:35 pmRNSHolding(s) in Company
20th Oct 20227:00 amRNSTransaction in Own Shares
19th Oct 20223:16 pmRNSReplacement Transaction in Own Shares
19th Oct 20227:00 amRNSTransaction in Own Shares
14th Oct 20227:00 amRNSShare Repurchase Programme
10th Oct 20224:41 pmRNSDirector/PDMR Shareholding
5th Oct 20227:00 amRNSHipgnosis Songs Fund announces interest rate hedge
3rd Oct 20227:00 amRNSHipgnosis Songs Fund announces debt refinancing
21st Sep 20222:59 pmRNSResult of Fourth AGM
21st Sep 20227:00 amRNSDividend Declaration
12th Sep 20224:42 pmRNSRevised Voting by Proxy Deadline
2nd Sep 20224:44 pmRNSHolding(s) in Company
8th Aug 20224:12 pmRNSHolding(s) in Company
3rd Aug 20227:00 amRNSNotice of Annual General Meeting
14th Jul 20227:01 amRNSNew Administration Agreements - Sacem & peermusic
14th Jul 20227:00 amRNSAnnual Financial Report
13th Jul 20227:00 amRNSDirector/PDMR Shareholding
4th Jul 20227:00 amRNSImpact of Copyright Royalty Board III Decision
12th May 20227:00 amRNSDividend Declaration
13th Apr 202212:05 pmRNSDirector/PDMR Shareholding
24th Feb 20227:00 amRNSKepler Trust Intelligence: New Research
8th Feb 20227:00 amRNSDividend Declaration
16th Dec 20217:00 amRNSHalf-year Report
14th Dec 202111:08 amRNSDirector/PDMR Shareholding
17th Nov 20217:00 amRNSCapital Markets Day
20th Oct 20214:00 pmRNSChange to Director Roles and Responsibilities
20th Oct 20217:00 amRNSDividend Declaration
12th Oct 202112:01 pmRNSNotice of Capital Markets Day

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.